Streetbeat News

Analyst Ratings

MCD

SBUX

McDonald's Corp (MCD) stock experienced a Golden Cross on Jan. 11, indicating bullish sentiment. The stock is up 20% since Oct. 12, 2023, and 9% over the past year, currently trading around $292-$295. Analysts have set price targets ranging from $317 to $340, with a consensus at $305.37 and a Buy rating. McDonald's is expanding its strategy with the beverage-centric CosMc, aiming to compete with Starbucks (SBUX) and planning to reach 50,000 restaurants by 2027.

Portfolio Pulse from Surbhi Jain

January 12, 2024 | 6:20 pm

MRO

Marathon Oil (NYSE:MRO) has received mixed analyst ratings over the past three months, with 8 analysts offering a range of bullish to indifferent perspectives. The average 12-month price target has been reduced by 5.74% to $31.69, with a high estimate of $39.00 and a low of $25.00. Several analysts have lowered their price targets, while a few have raised them. Marathon Oil focuses on unconventional resources in the U.S., with net proved reserves of 1.3 billion barrels of oil equivalent and a production average of 343 thousand barrels per day in 2022. The company's revenue declined by 11.8% as of September 30, 2023, but it maintains a strong net margin of 25.58% and an ROA of 2.27%, with a lower-than-average debt-to-equity ratio of 0.51.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 6:00 pm

BE

RBC Capital analyst Chris Dendrinos has maintained an Outperform rating on Bloom Energy (NYSE:BE) but reduced the price target from $24 to $21.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 5:48 pm

PANW

Cantor Fitzgerald analyst Jonathan Ruykhaver has reiterated an Overweight rating on Palo Alto Networks (NASDAQ:PANW) and maintained a price target of $280.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 5:45 pm

CRWD

Cantor Fitzgerald analyst Jonathan Ruykhaver has reiterated an Overweight rating on CrowdStrike Holdings (NASDAQ:CRWD) and maintained a price target of $240.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 5:43 pm

VRTX

Cantor Fitzgerald analyst Olivia Brayer has reiterated an Overweight rating on Vertex Pharmaceuticals (NASDAQ:VRTX) and maintained a price target of $415.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 5:41 pm

PSNY

Cantor Fitzgerald analyst Andres Sheppard has reiterated an Overweight rating on Polestar Automotive (NASDAQ:PSNY) and maintained a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 5:39 pm

LCID

Cantor Fitzgerald analyst Andres Sheppard has reiterated a Neutral rating on Lucid Group (NASDAQ:LCID) and maintained a price target of $6 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 5:35 pm

KOF

Coca-Cola Femsa SAB de (KOF) shares have risen following an upgrade from UBS, which changed its rating from Neutral to Buy.

Portfolio Pulse from Benzinga Newsdesk

January 12, 2024 | 5:15 pm

LYV

Roth Capital Partners analyst Eric Handler upgraded Live Nation Entertainment Inc (NYSE:LYV) to Buy and raised the price target from $92 to $114, citing positive secular demand for live events. Handler expects above-trend growth for the company over the next several years, with revenue and AOI estimates for 2024 above consensus. He also mentioned that the DOJ investigation is likely to have minimal impact and resolve in 2024. Despite the positive outlook, LYV shares declined by 0.91% to $90.48 in early trading on Friday.

Portfolio Pulse from Priya Nigam

January 12, 2024 | 5:09 pm